Status:
UNKNOWN
COVID-19 - Cytokine Storm
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Barzilai Medical Center
The Chaim Sheba Medical Center
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center study comparing clinical outcomes in patients with COVID-19 in subjects hospitalized at Hadassah and other hospitals for PCR or serology confirmed COVID-19 and compare the outco...
Detailed Description
Study Rationale Over 100 patients were hospitalized at Hadassah in the recent 2 months with the diagnosis of COVID-19. We would like to summarize the clinical outcomes and their correlation to a cyt...
Eligibility Criteria
Inclusion
- Patients, male or female of any age diagnosed with COVID-19, as defined below:
- Laboratory confirmation of SARS-CoV-2 infection by reverse transcription-polymerase chain reaction (RT-PCR) from any diagnostic sampling source.
- OR
- Serological evidence of SARS-CoV-2 infection
Exclusion
- None
Key Trial Info
Start Date :
June 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04474067
Start Date
June 28 2020
End Date
March 1 2021
Last Update
December 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Center
Jerusalem, Israel, 91120